180 related articles for article (PubMed ID: 7997881)
1. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding.
Thibodeau J; Cloutier I; Lavoie PM; Labrecque N; Mourad W; Jardetzky T; Sékaly RP
Science; 1994 Dec; 266(5192):1874-8. PubMed ID: 7997881
[TBL] [Abstract][Full Text] [Related]
2. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.
Kim J; Urban RG; Strominger JL; Wiley DC
Science; 1994 Dec; 266(5192):1870-4. PubMed ID: 7997880
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking of superantigens with class II major histocompatibility complex proteins.
Olson MA; Cuff L
J Mol Recognit; 1997; 10(6):277-89. PubMed ID: 9770652
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens.
Labrecque N; Thibodeau J; Mourad W; Sékaly RP
J Exp Med; 1994 Nov; 180(5):1921-9. PubMed ID: 7964467
[TBL] [Abstract][Full Text] [Related]
6. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
7. Altered orientation of streptococcal superantigen (SSA) on HLA-DR1 allows unconventional regions to contribute to SSA Vbeta specificity.
Stevens KR; Van M; Lamphear JG; Rich RR
J Immunol; 1996 Dec; 157(11):4970-8. PubMed ID: 8943403
[TBL] [Abstract][Full Text] [Related]
8. Superantigens. Gazing into the crystal ball.
Hsu PN; Huber BT
Curr Biol; 1995 Mar; 5(3):235-7. PubMed ID: 7780728
[TBL] [Abstract][Full Text] [Related]
9. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.
Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662
[TBL] [Abstract][Full Text] [Related]
10. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules.
Thibodeau J; Labrecque N; Denis F; Huber BT; Sékaly RP
J Exp Med; 1994 Mar; 179(3):1029-34. PubMed ID: 8113671
[TBL] [Abstract][Full Text] [Related]
11. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
[TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II.
Hudson KR; Tiedemann RE; Urban RG; Lowe SC; Strominger JL; Fraser JD
J Exp Med; 1995 Sep; 182(3):711-20. PubMed ID: 7650479
[TBL] [Abstract][Full Text] [Related]
14. Identification of MHC class II-associated peptides that promote the presentation of toxic shock syndrome toxin-1 to T cells.
Hogan RJ; VanBeek J; Broussard DR; Surman SL; Woodland DL
J Immunol; 2001 Jun; 166(11):6514-22. PubMed ID: 11359802
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal toxins bind to different sites on HLA-DR.
Chintagumpala MM; Mollick JA; Rich RR
J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
Scholl PR; Diez A; Geha RS
J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
[TBL] [Abstract][Full Text] [Related]
17. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
18. Multiple binding sites on the superantigen, staphylococcal enterotoxin B, imparts versatility in binding to MHC class II molecules.
Soos JM; Johnson HM
Biochem Biophys Res Commun; 1994 Jun; 201(2):596-602. PubMed ID: 8002991
[TBL] [Abstract][Full Text] [Related]
19. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
[TBL] [Abstract][Full Text] [Related]
20. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]